Arnon, Tadmor-Levy advises hospitals and a broad range of healthcare and life sciences companies, including pharmaceutical, biotechnology, medical device and digital health clients. The practice covers healthcare-related AI, strategic collaborations, clinical trials, regulatory compliance, investments and M&A, as well as privacy and data protection, corporate governance, hospital–insurer arrangements, IVF regulation, and cloud-based healthcare systems. Barry Levenfeld handles life sciences-related IP transactions, including strategic partnering and licensing; Daniel Green acts for technology transfer organisations at universities and medical centers; and Efrat Shapira-Orren is ‘one of a kind’. Yoheved Novogroder Shoshan and Miriam Friedmann are other experienced practitioners.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Sector knowledge
Testimonials
Collated independently by Legal 500 research team.
- ‘Efrat Shapira-Orren is one of a kind. She demonstrates a rare combination of intelligence, creativity, in-depth knowledge, business orientation, and great personality.’
- ‘Efrat Shapira-Orren is a great partner, a massive contributor to client teams and activity, and a pleasure to work with.’
- ‘Efrat Shapira-Orren possesses a very rare and unique in-depth breadth of knowledge and understanding of the healthcare field.’
- ‘Smart and sophisticated lawyers, with great business understanding, and very thorough and responsive.’
- ‘Efrat Shapira-Orren is talented and sharp.’
- ‘An extremely professional and knowledgeable team.’
Key clients
- Kaneka Corporation
- Immunai
- 4C Biomed
- Seagen
- ALYN Hospital
- Allergan
- Alma Lasers Ltd.
- Amylyx Pharmaceuticals
- Append Medical
- Samson Assuta Ashdod Public University Hospital (Registered Nonprofit)
- Assuta Medical Centers
- Barclays Capital
Work highlights
Advising Assuta Medical Centers on IVF incidents, regulation, digital innovation, and hospital operations.
Advising Oramed Pharmaceuticals on a $150m joint venture with HTIT for the global commercialisation of oral insulin.
Advising Alcon Pharmaceuticals on both the acquisition of Belkin Vision and an option to purchase Azura Ophthalmics.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Other key lawyers
Barry Levenfeld; Daniel Green; Efrat Shapira-Orren; Yoheved Novogroder Shoshan; Miriam Friedmann; Avital Bruker-Yamin; Avi Farchi; Asaf Tenenbaum